Market Update: Heron Therapeutics Inc (HRTX) Sees Negative Movement, Closing at 1.19

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Heron Therapeutics Inc (NASDAQ: HRTX) closed at $1.19 down -4.03% from its previous closing price of $1.24. In other words, the price has decreased by -$4.03 from its previous closing price. On the day, 1.5 million shares were traded. HRTX stock price reached its highest trading level at $1.25 during the session, while it also had its lowest trading level at $1.16.

Ratios:

For a deeper understanding of Heron Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.74 and its Current Ratio is at 2.28.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 13, 2024, initiated with a Buy rating and assigned the stock a target price of $7.

On April 23, 2024, CapitalOne started tracking the stock assigning a Overweight rating and target price of $6.

Needham reiterated its Buy rating for the stock on March 13, 2024, while the target price for the stock was revised from $4 to $5.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HRTX now has a Market Capitalization of 180993072 and an Enterprise Value of 288348960. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.26. Its current Enterprise Value per Revenue stands at 2.093 whereas that against EBITDA is -50.632.

Stock Price History:

Over the past 52 weeks, HRTX has reached a high of $3.93, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is -34.72%, while the 200-Day Moving Average is calculated to be -53.45%.

Shares Statistics:

For the past three months, HRTX has traded an average of 1.85M shares per day and 2547910 over the past ten days. A total of 150.29M shares are outstanding, with a floating share count of 144.08M. Insiders hold about 5.00% of the company’s shares, while institutions hold 80.49% stake in the company. Shares short for HRTX as of 1730332800 were 28810535 with a Short Ratio of 15.60, compared to 1727654400 on 31703092. Therefore, it implies a Short% of Shares Outstanding of 28810535 and a Short% of Float of 24.560000000000002.

Most Popular